In this short extra episode, Jim talks to Robin Hanson about possible dosage related effects on exposure and the related trade-offs of viral dose & deliberate infection strategies, the need for more investment in robustness, capacity vs flexibility, optimizing for adaptability, our lack of leadership, and more.